glp-1 news today october 23 2025 President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco breaks it down on the latest Alarming rise in weight loss

18 The SYNERGY-NASH (A Study of Tirzepatide [LY3298176] in Participants With Nonalcoholic Steatohepatitis) trial, 19 a phase 2b dose-finding study, randomized 190 patients with biopsy-confirmed MASH and stage 2 or 3 fibrosis to receive weekly injections of the GLP-1 and GIP dual agonist tirzepatide 5 mg, 10 mg, or 15 mg or placebo for 52 weeks

Diuretics and SGLT2 inhibitors can exacerbate fluid and electrolyte losses, whilst statins are independently associated with muscle-related symptoms

And then the third piece that I hope is has been made clear, but I just want to double click on it is if you are making a decision in any capacity to wean, which I prefer weaning period, or to come off of the medication, you have to go through a whole process of restarting your own and then we have to be checking it

: Effects of Oral L-Carnitine Administration in Narcolepsy Patients: A Randomized, Double-Blind, Cross-Over and Placebo-Controlled Trial PLoS One

Success in any business requires leadership, skills, commitment, and dedication, and will depend on your efforts